Literature DB >> 15994443

Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, pigment epithelium-derived factor, in human atherosclerotic plaques.

Hiromitsu Baba1, Yoshikazu Yonemitsu, Toshiaki Nakano, Mitsuho Onimaru, Masanori Miyazaki, Yasuhiro Ikeda, Shinji Sumiyoshi, Yasuji Ueda, Mamoru Hasegawa, Ichiro Yoshino, Yoshihiko Maehara, Katsuo Sueishi.   

Abstract

OBJECTIVE: To assess the expression and distribution of a neurotrophic/antiangiogenic factor, pigment epithelium-derived factor (PEDF), related to angiogenesis that is a possibly key event during atherogenesis in human atherosclerotic plaques. METHODS AND
RESULTS: Twenty fresh aortic samples were used for reverse-transcription polymerase chain reaction (RT-PCR), Western blot, and immunohistochemistry (IHC). In addition, 80 stocked paraffin blocks of coronary arteries from 40 autopsy cases were also used. IHC revealed divergent staining patterns for PEDF in both the aortas and the coronary arteries tested, ie, "cytoplasmic staining" or "extracellular deposition," were observed, respectively. In the areas showing cytoplasmic staining, double PEDF was expressed in a majority of the foamy macrophages and in some smooth muscle cells, and the PEDF-positive cell frequency was positively correlated with that of microvessels in a cell-rich area in the coronary arteries (P<0.0001). Inversely, extracellular deposition of PEDF was seen in acellular areas and was negatively correlated with the number of microvessels (P=0.0003).
CONCLUSIONS: These results suggest that PEDF may function as an antiangiogenic factor when it is deposited onto the extracellular matrix. Thus, PEDF may play a significant role in determining the balance of angiogenesis/ antiangiogenesis during atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994443     DOI: 10.1161/01.ATV.0000175759.78338.1e

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans.

Authors:  Atsushi Sekiya; Hitomi Okano-Kosugi; Chisato M Yamazaki; Takaki Koide
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

2.  PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL.

Authors:  Hao Zhang; Teng Sun; Xia Jiang; Hongli Yu; Meng Wang; Tengteng Wei; Huazhu Cui; Wei Zhuang; Zhiwei Liu; Zhongming Zhang; Hongyan Dong
Journal:  J Transl Med       Date:  2015-02-21       Impact factor: 5.531

3.  Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/β-catenin pathway.

Authors:  Shouyuan Ma; Shutong Yao; Hua Tian; Peng Jiao; Nana Yang; Ping Zhu; Shucun Qin
Journal:  Lipids Health Dis       Date:  2017-02-07       Impact factor: 3.876

Review 4.  The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process.

Authors:  Shouyuan Ma; Shuxia Wang; Man Li; Yan Zhang; Ping Zhu
Journal:  Lipids Health Dis       Date:  2018-10-17       Impact factor: 3.876

5.  The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts.

Authors:  Kathrin Rychli; Christoph Kaun; Philipp J Hohensinner; Adrian J Dorfner; Stefan Pfaffenberger; Alexander Niessner; Michael Bauer; Wolfgang Dietl; Bruno K Podesser; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.